DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)
18.22
-0.16 (-0.87%)
Sep 16, 2026, 3:00 PM CST
SHA:603233 Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, SHA:603233 stock has a consensus rating of "Buy" and an average price target of ¥23.75. The average 1-year stock price forecast is 30.35% higher than the current stock price, while the lowest is ¥15.00 (-17.67%) and the highest is ¥26.40 (+44.90%).
Price Target: ¥23.75 (+30.35%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for SHA:603233 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Buy | 3 | 4 | 4 | 4 | 5 | 5 |
| Hold | 1 | 1 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 1 |
| Total | 10 | 11 | 10 | 10 | 11 | 12 |
Financial Forecast
Revenue This Year
29.54B
from 27.50B
Increased by 7.41%
Revenue Next Year
32.52B
from 29.54B
Increased by 10.09%
EPS This Year
1.31
from 1.07
Increased by 22.33%
EPS Next Year
1.52
from 1.31
Increased by 16.48%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.